NO20033642L - Nytt farmasöytisk preparat av interferon-gamma eller pirfenidon med molekyl¶re diagnostika for forbedret behandling av interstitiellelungesykdommer - Google Patents
Nytt farmasöytisk preparat av interferon-gamma eller pirfenidon med molekyl¶re diagnostika for forbedret behandling av interstitiellelungesykdommerInfo
- Publication number
- NO20033642L NO20033642L NO20033642A NO20033642A NO20033642L NO 20033642 L NO20033642 L NO 20033642L NO 20033642 A NO20033642 A NO 20033642A NO 20033642 A NO20033642 A NO 20033642A NO 20033642 L NO20033642 L NO 20033642L
- Authority
- NO
- Norway
- Prior art keywords
- pirfenidone
- interferon
- gamma
- pharmaceutical preparation
- interstitial lung
- Prior art date
Links
- 102000008070 Interferon-gamma Human genes 0.000 title 1
- 108010074328 Interferon-gamma Proteins 0.000 title 1
- 208000029523 Interstitial Lung disease Diseases 0.000 title 1
- 229960003130 interferon gamma Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical compound C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 title 1
- 229960003073 pirfenidone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01130011 | 2001-12-18 | ||
PCT/CH2002/000691 WO2003051388A2 (en) | 2001-12-18 | 2002-12-12 | Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033642D0 NO20033642D0 (no) | 2003-08-15 |
NO20033642L true NO20033642L (no) | 2003-10-17 |
Family
ID=8179579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033642A NO20033642L (no) | 2001-12-18 | 2003-08-15 | Nytt farmasöytisk preparat av interferon-gamma eller pirfenidon med molekyl¶re diagnostika for forbedret behandling av interstitiellelungesykdommer |
Country Status (9)
Country | Link |
---|---|
US (2) | US20060270618A1 (pt) |
EP (1) | EP1455813B1 (pt) |
JP (1) | JP2005528082A (pt) |
CN (1) | CN1620309A (pt) |
AU (1) | AU2002347182A1 (pt) |
BR (1) | BR0207310A (pt) |
CA (1) | CA2470763A1 (pt) |
NO (1) | NO20033642L (pt) |
WO (1) | WO2003051388A2 (pt) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
EP1455813B1 (en) * | 2001-12-18 | 2015-07-15 | mondoBIOTECH AG | Interferon gamma in combination with a diagnostic array for use in the improved treatment of idiopathic pulmonary fibrosis |
CA2496577A1 (en) * | 2002-08-28 | 2004-03-11 | Intermune, Inc. | Combination therapy for treatment of fibrotic disorders |
CA2532135A1 (en) * | 2003-07-14 | 2005-01-20 | Mondobiotech Laboratories Anstalt | Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
EP3184630B1 (en) * | 2005-09-23 | 2019-07-17 | TiGenix, S.A.U. | Cell populations having immunoregulatory activity, method for isolation and uses |
US8425935B2 (en) | 2005-12-21 | 2013-04-23 | Basf Se | Pharmaceutical formulation for producing rapidly disintegrating tablets |
CN101631877A (zh) * | 2007-01-09 | 2010-01-20 | 百时美施贵宝公司 | 用于预测可与前列腺细胞中蛋白酪氨酸激酶和/或蛋白酪氨酸激酶途径相互作用和/或对其进行调节的化合物的活性的多核苷酸的鉴定 |
CA2686964A1 (en) | 2007-06-06 | 2008-12-11 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
AU2008265595B2 (en) * | 2007-06-20 | 2014-12-04 | PureTech LYT 100 Inc. | Substituted N-Aryl pyridinones as fibrotic inhibitors |
JP5312459B2 (ja) | 2007-08-02 | 2013-10-09 | ジリード バイオロジクス,インク. | Loxおよびloxl2阻害剤ならびにこれらの使用 |
JP5583592B2 (ja) * | 2007-11-30 | 2014-09-03 | ニューリンク ジェネティクス コーポレイション | Ido阻害剤 |
WO2010065755A1 (en) | 2008-12-04 | 2010-06-10 | Concert Pharmaceuticals, Inc. | Deuterated pyridinones |
US9107935B2 (en) * | 2009-01-06 | 2015-08-18 | Gilead Biologics, Inc. | Chemotherapeutic methods and compositions |
AU2010206543A1 (en) * | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
WO2011022670A1 (en) * | 2009-08-21 | 2011-02-24 | Arresto Biosciences, Inc | In vivo screening assays |
AU2010284000A1 (en) * | 2009-08-21 | 2012-03-22 | Gilead Biologics, Inc. | In vitro screening assays |
AU2010284036B2 (en) | 2009-08-21 | 2014-12-18 | Gilead Biologics, Inc. | Catalytic domains from lysyl oxidase and LOXL2 |
RU2012110587A (ru) * | 2009-08-21 | 2013-09-27 | Джилид Байолоджикс, Инк. | Терапевтические способы и композиции |
RU2561672C2 (ru) * | 2009-08-21 | 2015-08-27 | Джилид Байолоджикс, Инк. | Способы и композиции для лечения фиброзных заболеваний легких |
US20120329666A1 (en) * | 2009-10-05 | 2012-12-27 | Duke University | Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use |
SG183174A1 (en) | 2010-02-04 | 2012-09-27 | Gilead Biologics Inc | Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor |
EP2580240B1 (en) | 2010-06-14 | 2018-11-28 | Lykera Biomed S.A. | S100a4 antibodies and therapeutic uses thereof |
US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
AU2012212269B2 (en) | 2011-01-31 | 2016-05-19 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
DK3460054T3 (da) | 2013-03-15 | 2021-01-18 | Atyr Pharma Inc | Histidyl-tRNA-syntetase-Fc-konjugater |
CN103467612B (zh) * | 2013-09-09 | 2015-06-24 | 山东省农业科学院农产品研究所 | 一种从热榨花生粕中同步提取多糖和蛋白的方法 |
NZ722927A (en) | 2014-01-10 | 2022-07-29 | Avalyn Pharma Inc | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
GB201408100D0 (en) * | 2014-05-07 | 2014-06-18 | Sec Dep For Health The | Detection method |
JOP20200115A1 (ar) * | 2014-10-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | تركيبات وطرق لتثبيط التعبير الجيني عن hao1 (حمض أوكسيداز هيدروكسيلي 1 (أوكسيداز جليكولات)) |
EP3215170A4 (en) | 2014-11-05 | 2018-04-25 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
EP3344283A1 (en) * | 2015-08-31 | 2018-07-11 | Merck Patent GmbH | Methods for the modulation of lgals3bp to treat systemic lupus erythematosus |
CN107356761B (zh) * | 2016-05-09 | 2020-03-31 | 上海华盈生物医药科技有限公司 | 接骨木凝集素及结合珠蛋白相关蛋白的用途 |
TWI783957B (zh) | 2016-12-23 | 2022-11-21 | 美商伊繆諾金公司 | 靶向adam9之免疫共軛物及其使用方法 |
AR110424A1 (es) | 2016-12-23 | 2019-03-27 | Macrogenics Inc | Moléculas de unión a adam9 y métodos de uso de las mismas |
CN106860855B (zh) * | 2017-03-01 | 2021-06-11 | 成都惠泰生物医药有限公司 | 多肽及多肽衍生物在预防和治疗纤维化疾病中的应用 |
CN109384830B (zh) * | 2017-08-09 | 2021-12-03 | 成都惠泰生物医药有限公司 | 多肽、多肽片段及其衍生物在防治纤维化疾病中的应用 |
CA3060514A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
CN109722455B (zh) * | 2017-10-31 | 2022-03-11 | 中国科学院天津工业生物技术研究所 | 微生物发酵生产谷内酯的方法、工程菌及应用 |
KR20210061995A (ko) | 2018-06-26 | 2021-05-28 | 이뮤노젠 아이엔씨 | Adam9를 표적으로 하는 면역콘쥬게이트 및 이를 이용하는 방법들 |
CN111103426B (zh) * | 2019-12-19 | 2022-10-21 | 广州市妇女儿童医疗中心 | Lap3作为儿童腺病毒肺炎诊断标志物的应用 |
CN113846150A (zh) * | 2020-06-28 | 2021-12-28 | 深圳华大生命科学研究院 | 核酸分子及其应用 |
TW202302155A (zh) | 2021-03-08 | 2023-01-16 | 美商伊繆諾金公司 | 用於增加靶向adam9之免疫結合物治療癌症之功效的方法 |
CN114276418A (zh) * | 2021-12-28 | 2022-04-05 | 中国科学技术大学 | 一种可用于调控微管、治疗脱髓鞘病变靶向治疗的rna |
CN114452376A (zh) * | 2022-01-21 | 2022-05-10 | 上海市精神卫生中心(上海市心理咨询培训中心) | 胰岛素样生长因子结合蛋白2在制备治疗神经脱髓鞘性疾病的药物中的应用 |
CN114636825B (zh) * | 2022-03-02 | 2022-12-20 | 中国医学科学院北京协和医院 | Golm1作为肺纤维化生物标记物、靶点的应用及检测Golm1的试剂的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
IE873041L (en) * | 1987-11-11 | 1989-05-11 | Ailbe Brennan | Viral antigens, diagnostic assay therefor and vaccines¹containing them |
WO1990006952A1 (en) | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
DK0403333T3 (da) * | 1989-06-02 | 2000-03-20 | Pasteur Institut | Nukleotidsekvenser stammende fra genomet i retrovirus af typen HIV-1, HIV-2 og SIV og deres anvendelse, fortrinsvis til opf |
WO1994026249A1 (en) * | 1993-05-07 | 1994-11-24 | Margolin Solomon B | Compositions and methods for reparation and prevention of fibrotic lesions |
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
ES2093554B1 (es) * | 1995-02-17 | 1997-07-01 | Inst De Salud Carlos Iii | Procedimientos de amplificacion de genoma y mezclas de oligonucleotidos iniciadores para la deteccion y la identificacion de agentes infecciosos relacionados. |
EP0795332B1 (en) * | 1996-03-14 | 2005-06-01 | Mondobiotech Interferon SA | Medical use of gamma-interferon in interstitial lung diseases |
DE69939388D1 (de) * | 1998-09-24 | 2008-10-02 | Innogenetics Nv | Identizierung von microorganismen,die akute atemwegsinfektionen verursachen |
JP2002540801A (ja) * | 1999-04-02 | 2002-12-03 | インタールーキン ジェネティックス インク | 間質性肺疾患の危険性の予測 |
CA2387089A1 (en) * | 1999-11-10 | 2001-05-17 | Mondobiotech Sa | Interferon gamma for the treatment of asthma |
JP2003513681A (ja) * | 1999-11-12 | 2003-04-15 | マキシゲン・ホールディングス・リミテッド | インターフェロンガンマ・コンジュゲート |
EP1455813B1 (en) * | 2001-12-18 | 2015-07-15 | mondoBIOTECH AG | Interferon gamma in combination with a diagnostic array for use in the improved treatment of idiopathic pulmonary fibrosis |
-
2002
- 2002-12-12 EP EP02782602.3A patent/EP1455813B1/en not_active Expired - Lifetime
- 2002-12-12 BR BR0207310-2A patent/BR0207310A/pt not_active Application Discontinuation
- 2002-12-12 JP JP2003552321A patent/JP2005528082A/ja active Pending
- 2002-12-12 CA CA002470763A patent/CA2470763A1/en not_active Abandoned
- 2002-12-12 WO PCT/CH2002/000691 patent/WO2003051388A2/en active Application Filing
- 2002-12-12 CN CNA02828206XA patent/CN1620309A/zh active Pending
- 2002-12-12 AU AU2002347182A patent/AU2002347182A1/en not_active Abandoned
- 2002-12-12 US US10/498,079 patent/US20060270618A1/en not_active Abandoned
-
2003
- 2003-08-15 NO NO20033642A patent/NO20033642L/no not_active Application Discontinuation
-
2008
- 2008-04-25 US US12/110,151 patent/US20090142301A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2470763A1 (en) | 2003-06-26 |
US20060270618A1 (en) | 2006-11-30 |
CN1620309A (zh) | 2005-05-25 |
EP1455813A2 (en) | 2004-09-15 |
EP1455813B1 (en) | 2015-07-15 |
US20090142301A1 (en) | 2009-06-04 |
AU2002347182A1 (en) | 2003-06-30 |
JP2005528082A (ja) | 2005-09-22 |
WO2003051388A3 (en) | 2003-10-30 |
NO20033642D0 (no) | 2003-08-15 |
BR0207310A (pt) | 2004-08-17 |
WO2003051388A2 (en) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033642D0 (no) | Nytt farmasöytisk preparat av interferon-gamma eller pirfenidon med molekyl¶re diagnostika for forbedret behandling av interstitiellelungesykdommer | |
LTC1562603I2 (lt) | Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui | |
CY2014019I1 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
NO20033594D0 (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
NO20054180D0 (no) | Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner | |
NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
CY2017014I2 (el) | Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων | |
NO20050569D0 (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
NO20053920D0 (no) | Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler. | |
NO20041277L (no) | Farmasoytiske preparater for behandling av astma. | |
NO20034590L (no) | Fremgangsmåter for behandling av vaskul¶r sykdom | |
NO20044402L (no) | Kombinasjonsbehandling av kemokine-medierte sykdommer | |
NO20043000L (no) | Et preparat for behandling av nevrocerebrovaskulaere sykdommer | |
ZA200701584B (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
EA200400881A1 (ru) | Азаарилпиперазины | |
CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
DE60213234D1 (de) | 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts | |
NO20020784D0 (no) | Medikament for behandling av brudd | |
AU2002322263A1 (en) | Eglin c based drugs for treatment of disease | |
NO20055137D0 (no) | Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer | |
EE200100527A (et) | Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |